These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9952106)

  • 21. Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma.
    Møller MB; Gerdes AM; Skjødt K; Mortensen LS; Pedersen NT
    Clin Cancer Res; 1999 May; 5(5):1085-91. PubMed ID: 10353742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specificity of PCR-based clonality analysis of immunoglobulin heavy chain gene rearrangements for the detection of bone marrow involvement by low-grade B-cell lymphomas.
    Brinckmann R; Kaufmann O; Reinartz B; Dietel M
    J Pathol; 2000 Jan; 190(1):55-60. PubMed ID: 10640992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 in lymphomas of mucosal-associated lymphoid tissues.
    Levy V; Miller C; Koeffler HP; Said JW
    Mod Pathol; 1996 Mar; 9(3):245-8. PubMed ID: 8685222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases.
    Thériault C; Galoin S; Valmary S; Selves J; Lamant L; Roda D; Rigal-Huguet F; Brousset P; Delsol G; Al Saati T
    Mod Pathol; 2000 Dec; 13(12):1269-79. PubMed ID: 11144922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Hodgkin lymphomas of mice.
    Hori M; Xiang S; Qi CF; Chattopadhyay SK; Fredrickson TN; Hartley JW; Kovalchuk AL; Bornkamm GW; Janz S; Copeland NG; Jenkins NA; Ward JM; Morse HC
    Blood Cells Mol Dis; 2001; 27(1):217-22. PubMed ID: 11358382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in protein expression in p53 deleted spontaneous thymic lymphomas.
    Honoré B; Vorum H; Pedersen AE; Buus S; Claësson MH
    Exp Cell Res; 2004 Apr; 295(1):91-101. PubMed ID: 15051493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
    Baxter EW; Blyth K; Cameron ER; Neil JC
    J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric T-cell lymphoma with cytotoxic phenotype.
    Sugita S; Iijima T; Furuya S; Kano J; Yanaka A; Ohta K; Kojima H; Noguchi M
    Pathol Int; 2007 Feb; 57(2):108-14. PubMed ID: 17300676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canine indolent nodular lymphoma.
    Valli VE; Vernau W; de Lorimier LP; Graham PS; Moore PF
    Vet Pathol; 2006 May; 43(3):241-56. PubMed ID: 16672571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
    Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T
    Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features.
    Balagué O; Martínez A; Colomo L; Roselló E; Garcia A; Martínez-Bernal M; Palacín A; Fu K; Weisenburger D; Colomer D; Burke JS; Warnke RA; Campo E
    Am J Surg Pathol; 2007 Sep; 31(9):1310-22. PubMed ID: 17721185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development.
    Dubé N; Bourdeau A; Heinonen KM; Cheng A; Loy AL; Tremblay ML
    Cancer Res; 2005 Nov; 65(21):10088-95. PubMed ID: 16267035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53-mediated apoptosis prevents the accumulation of progenitor B cells and B-cell tumors.
    Slatter TL; Ganesan P; Holzhauer C; Mehta R; Rubio C; Williams G; Wilson M; Royds JA; Baird MA; Braithwaite AW
    Cell Death Differ; 2010 Mar; 17(3):540-50. PubMed ID: 19779492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas.
    Shin MS; Fredrickson TN; Hartley JW; Suzuki T; Akagi K; Morse HC
    Cancer Res; 2004 Jul; 64(13):4419-27. PubMed ID: 15231650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marginal zone-related neoplasms of splenic and nodal origin.
    Arcaini L; Paulli M; Boveri E; Magrini U; Lazzarino M
    Haematologica; 2003 Jan; 88(1):80-93. PubMed ID: 12551831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells.
    Street SE; Hayakawa Y; Zhan Y; Lew AM; MacGregor D; Jamieson AM; Diefenbach A; Yagita H; Godfrey DI; Smyth MJ
    J Exp Med; 2004 Mar; 199(6):879-84. PubMed ID: 15007091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphomagenesis in AKR.Fv-1b congenic mice.
    Haran-Ghera N; Peled A; Brightman BK; Fan H
    Cancer Res; 1993 Jul; 53(14):3433-8. PubMed ID: 8324753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of passive anti-viral immunotherapy in AKR mice: II. Susceptibility to B cell lymphomagenesis.
    Haran-Ghera N; Peled A; Canaani E; Caspi Y; Haimovich J; Shaft D; Resnitzky P; Brightman BK; Fan H
    Leukemia; 1995 Nov; 9(11):1940-7. PubMed ID: 7475287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.